Patients with lymphatic metastasis of cutaneous malignant melanoma benefit from sentinel lymphonodectomy and early excision of their nodal disease
- 1 January 2004
- journal article
- research article
- Published by Elsevier in European Journal Of Cancer
- Vol. 40 (2) , 212-218
- https://doi.org/10.1016/j.ejca.2003.07.003
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Langzeitergebnisse der adjuvanten Chemotherapie nach therapeutischer Lymphknotendissektion beim malignen Melanom der HautDie Dermatologie, 2002
- Final Version of the American Joint Committee on Cancer Staging System for Cutaneous MelanomaJournal of Clinical Oncology, 2001
- The argument against sentinel node biopsy for malignant melanomaBMJ, 2000
- Adjuvant Therapy of Malignant Melanoma and the Role of Sentinel Node MappingPublished by Springer Nature ,2000
- Efficacy of Lymphatic Mapping, Sentinel Lymphadenectomy, and Selective Complete Lymph Node Dissection as a Therapeutic Procedure for Early-Stage MelanomaAnnals of Surgical Oncology, 1999
- Multi-Institutional Melanoma Lymphatic Mapping Experience: The Prognostic Value of Sentinel Lymph Node Status in 612 Stage I or II Melanoma PatientsJournal of Clinical Oncology, 1999
- Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trialThe Lancet, 1998
- Efficacy of an Elective Regional Lymph Node Dissection of 1 to 4 mm Thick Melanomas for Patients 60 Years of Age and YoungerAnnals of Surgery, 1996
- Technical Details of Intraoperative Lymphatic Mapping for Early Stage MelanomaArchives of Surgery, 1992
- Inefficacy of Immediate Node Dissection in Stage 1 Melanoma of the LimbsNew England Journal of Medicine, 1977